Splenic Myelolipomas in the Domestic Cat—To Operate or Not to Operate?
Diana J. Kennedy,
Helena M. T. Ferreira,
Melanie J. Dobromylskyj,
Stefan Hobi,
Angel Almendros,
Paweł M. Bęczkowski
Affiliations
Diana J. Kennedy
Beaumont Veterinary Hospital, 172 Oxford Rd., Kidlington OX5 1EA, UK
Helena M. T. Ferreira
Zoetis Virtual Laboratory, Leatherhead KT22 7LP, UK
Melanie J. Dobromylskyj
Finn Pathologists, Histopathology Department, One Eyed Lane, Diss IP21 5TT, UK
Stefan Hobi
Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong SAR, China
Angel Almendros
Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong SAR, China
Paweł M. Bęczkowski
Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong SAR, China
Myelolipoma is a benign, typically inert neoplasm of uncertain aetiology that is rarely reported in cats. Although commonly asymptomatic, in some cases, myelolipomas can cause abdominal discomfort or present with rupture and haemorrhage. Here, we describe a rare case of a splenic myelolipoma in a Domestic Long Hair cat in which, after extensive diagnostic investigations, clinical signs of hyporexia and weight loss were attributable to the presence of an intra-abdominal mass. The patient was treated by splenectomy and unexpectedly died during the post-operative period. Although splenectomy appears to be a sensible intervention in symptomatic patients, the optimal management of splenic myelolipomas in cats remains unknown. The risk–benefit ratio of surgical management needs to be carefully considered, and therapeutic intervention should be tailored individually to each patient.